Strategies to Increase Genome Editing Frequencies and to Facilitate the Identification of Edited Cells
The power of genome editing is increasingly recognized as it has become more accessible to a wide range of scientists and a wider range of uses has been reported. Nonetheless, an important practical aspect of the strategy is develop methods to increase the frequency of genome editing or methods that enrich for genome-edited cells such that they can be more easily identified. This chapter discusses several different approaches including the use of cold-shock, exonucleases, surrogate markers, specialized donor vectors, and oligonucleotides to enhance the frequency of genome editing or to facilitate the identification of genome-edited cells.
Key wordsGenome editing Engineered nuclease Homologous recombination Nonhomologous end joining Homing endonuclease Zinc finger nuclease TAL effector nuclease CRISPR/Cas9
- 10.Boissel S, Jarjour J, Astrakhan A, Adey A, Gouble A, Duchateau P, Shendure J, Stoddard BL, Certo MT, Baker D, Scharenberg AM (2013) megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering. Nucleic Acids Res. doi:10.1093/nar/gkt1224Google Scholar
- 11.Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39(12):e82. doi: 10.1093/nar/gkr218 PubMedCentralPubMedCrossRefGoogle Scholar
- 17.Certo MT, Gwiazda KS, Kuhar R, Sather B, Curinga G, Mandt T, Brault M, Lambert AR, Baxter SK, Jacoby K, Ryu BY, Kiem HP, Gouble A, Paques F, Rawlings DJ, Scharenberg AM (2012) Coupling endonucleases with DNA end-processing enzymes to drive gene disruption. Nat Methods 9(10):973–975. doi: 10.1038/nmeth.2177 PubMedCentralPubMedCrossRefGoogle Scholar
- 22.Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L (2009) Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5(1):97–110. doi: 10.1016/j.stem.2009.05.023 PubMedCentralPubMedCrossRefGoogle Scholar